Permethrin and Januvia drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Permethrin (permethrin) and Januvia (sitagliptin phosphate). Common drug interactions include dry skin among females and pain among males.
The phase IV clinical study analyzes what interactions people have when they take Permethrin and Januvia. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.
What is Permethrin?
Permethrin has active ingredients of permethrin. It is often used in scabies. eHealthMe is studying from 1,547 Permethrin users. Check the latest studies of Permethrin.
What is Januvia?
Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. eHealthMe is studying from 72,818 Januvia users. Check the latest studies of Januvia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
31 people who take Permethrin and Januvia together, and have interactions are studied.

What are the common drug interactions of Permethrin and Januvia, by gender? *:
female:
- Dry skin
- Epistaxis (bleed from the nose)
- Nasal discomfort
- Pruritus (severe itching of the skin)
- Sinusitis (inflammation of sinus)
- Skin disorder (skin disease)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Upper-airway cough syndrome
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
male:
- Pain
- Abscess limb (limb infection)
- Perirectal abscess
- Rectal abscess (pus in rectum)
- Scar
- Scrotal abscess (pus in scrotum)
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Decreased activity
What are the common drug interactions of Permethrin and Januvia, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Abscess limb (limb infection)
- Cellulitis (infection under the skin)
- Cellulitis of male external genital organ (infection of male genitals soft tissue)
- Colon gangrene (colon tissue dies)
- Deformity (disfigurement)
- Infected dermal cyst
- Nerve injury
- Pain
- Perineal abscess
- Perirectal abscess
50-59:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Decreased activity
- Emotional distress
- Impaired work ability
- Pain
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine)
- Quality of life decreased
- Malignant melanoma (skin cancer rises from melancytes)
60+:
- Arthritis (form of joint disorder that involves inflammation of one or more joints)
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Sinusitis (inflammation of sinus)
- Skin disorder (skin disease)
- Thrombosis (formation of a blood clot inside a blood vessel)
- Upper-airway cough syndrome
- Vertigo
- Back pain
- Memory impairment
- Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
What are the existing conditions these people have? *
- Psoriasis (immune-mediated disease that affects the skin): 13 people, 41.94%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 16.13%
- Pain: 4 people, 12.90%
- Weight Decreased: 3 people, 9.68%
- Type 2 Diabetes: 3 people, 9.68%
- Hypotension (abnormally low blood pressure): 3 people, 9.68%
- Hiv Infection: 3 people, 9.68%
- Infection: 2 people, 6.45%
- High Blood Pressure: 2 people, 6.45%
- High Blood Cholesterol: 2 people, 6.45%
* Approximation only. Some reports may have incomplete information.
Do you take Permethrin and Januvia?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Permethrin (1,547 reports)
- Januvia (72,818 reports)
Browse all drug interactions of Permethrin and Januvia:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Permethrin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Januvia:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Permethrin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Januvia and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
- Liao KF, Lin CL, Lai SW, Chen WC, "Sitagliptin use and risk of acute pancreatitis in type 2 diabetes mellitus: a population-based case-control study in Taiwan", European journal of internal medicine, 2016 Jan .
- Belice T, Yuce S, Kizilkaya B, Kurt A, Cure E, "Noncardiac pulmonary edema induced by sitagliptin treatment", Journal of family medicine and primary care, 2014 Jan .
- Misgar, R. A., Bhat, J. A., Wani, A. I., & Bashir, M. I., "Sitagliptin induced splenic infarcts", Clinical Diabetology, 2014 Jan .
- Stricklin SM, Stoecker WV, Rader RK, Hood AF, Litt JZ, Schuman TP, "Persistent edematous-plaque photosensitivity observed with sitagliptin phosphate (Januvia?)", Dermatology online journal, 2012 Feb .
How the study uses the data?
The study uses data from the FDA. It is based on permethrin and sitagliptin phosphate (the active ingredients of Permethrin and Januvia, respectively), and Permethrin and Januvia (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Divalproex Sodium cause Aortic Calcification? - 3 seconds ago
- Could Humalog cause Vitreous Floaters? - 10 seconds ago
- Could Augmentin '125' cause Ear Pain? - 10 seconds ago
- Rectal Cancer and Muscle Spasms - 15 seconds ago
- Drug interactions of Droperidol and Sugammadex Sodium - 17 seconds ago
- Could Skyrizi cause Peripheral Swelling? - 21 seconds ago
- Could Atorvastatin Calcium cause Chronic Obstructive Pulmonary Disease? - 24 seconds ago
- Could Omeprazole cause Urine Osmolarity Increased? - 26 seconds ago
- Drug interactions of Alprazolam and Propulsid - 27 seconds ago
- Could Atorvastatin Calcium cause Infarction? - 30 seconds ago